Ado Trastuzumab Emtansine
About Ado Trastuzumab Emtansine
Ado Trastuzumab Emtansine is a specialised injection used to treat a specific type of breast cancer known as HER2-positive breast cancer. It is prescribed for patients whose cancer has either spread to other parts of the body (metastatic) or remains after initial treatments. This medicine is designed to target and destroy cancer cells while minimising damage to healthy tissue.
This injection is typically given by a healthcare professional in a clinic or hospital setting, usually once every three weeks. Keeping your appointments on a consistent schedule is highly important to ensure the medicine works effectively. Because it is given directly into a vein, you do not need to worry about taking it with or without food, though maintaining a healthy diet and staying well-hydrated can help support your body during treatment.
While Ado Trastuzumab Emtansine is highly targeted, it can still cause common side effects such as nausea, muscle pain, and feeling very tired. It is crucial to contact your healthcare provider immediately if you experience signs of more serious issues, such as yellowing of your skin or eyes, severe shortness of breath, or sudden swelling in your legs.
Do not take this if you are pregnant, as it can cause severe harm or death to an unborn baby. Before starting treatment, you must tell your doctor if you have a history of liver damage, heart conditions, or bleeding problems, as these issues may require close monitoring or a change in your treatment plan.
Certain medications, including strong liver enzyme inhibitors, may interact with Ado Trastuzumab Emtansine and increase the risk of side effects. It is also highly recommended that breastfeeding individuals or older adults speak with their doctor to understand the specific risks and necessary precautions before receiving this medicine.
Uses of Ado Trastuzumab Emtansine
Medicinal Benefits
Ado Trastuzumab Emtansine helps treat certain types of HER2-positive cancer by delivering targeted chemotherapy directly to cancer cells. With regular use as prescribed, it helps control disease progression, reduce the risk of cancer recurrence, and support better long-term treatment outcomes.
- Delivers Targeted Cancer Treatment: By combining a targeted antibody with a chemotherapy medicine, this treatment delivers the anticancer drug directly to HER2-positive cancer cells, helping limit damage to many healthy cells compared with conventional chemotherapy.
- Reduces the Risk of Cancer Recurrence: When used for early-stage HER2-positive breast cancer, this medicine helps lower the risk of the cancer returning and supports long-term recovery after initial treatment.
- Helps Control Advanced Cancer: In advanced HER2-positive cancers, this medicine helps slow disease progression, relieve cancer-related symptoms, and support better quality of life by helping patients maintain their daily activities for longer.
Directions for Use
- Follow your doctor’s instructions on the dosage and timing of this medication.
- Ado Trastuzumab Emtansine will be administered by a nurse or doctor.
- Do not self-administer.
Storage
Side Effects of Ado Trastuzumab Emtansine
Common Side Effects (Usually mild):
- Feeling unusually tired or weak (fatigue)
- Nausea and decreased appetite
- Muscle, bone, or joint pain
- Headache or trouble sleeping
Serious Side Effects (Consult a doctor right away):
- Signs of liver damage, such as yellowing of the eyes or skin, dark urine, or severe stomach pain
- Signs of heart problems, such as unexpected shortness of breath, coughing, or swelling in your ankles or feet
- Unusual bruising, bleeding that will not stop, or blood in your urine or stool
- Signs of an allergic reaction, including hives, difficulty breathing, or swelling of your face, lips, tongue, or throat
Drug Warnings
- Watch your injection site closely during the infusion; tell your nurse immediately if you feel pain, burning, redness, or swelling where the needle is placed.
- Have your liver function and heart function (including an echocardiogram) checked regularly as recommended by your doctor before and during treatment.
- Use highly effective birth control during treatment and for at least 7 months after your final dose to prevent pregnancy.
- Monitor your temperature regularly and report any fever, chills, or signs of infection to your healthcare team immediately.
- Do not receive any live vaccines while undergoing treatment with Ado Trastuzumab Emtansine without consulting your doctor first.
Drug Interactions
- Strong CYP3A4 Inhibitors: Certain antifungal medicines, antiviral medicines, and other strong CYP3A4 inhibitors may increase the levels of Ado Trastuzumab Emtansine in your bloodstream, raising the risk of side effects. Your doctor may recommend dose adjustments or closer monitoring during treatment.
- Blood Thinners (Anticoagulants): Taking Ado Trastuzumab Emtansine together with blood-thinning medicines, such as anticoagulants, may increase the risk of serious bleeding. Inform your doctor if you are using any medicines to prevent blood clots so appropriate monitoring can be arranged.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
consult your doctorIt is unknown whether Ado Trastuzumab Emtansine interacts with alcohol or not. Consult your doctor if you have any concerns.
Pregnancy
unsafeAdo Trastuzumab Emtansine is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Ado Trastuzumab Emtansine. Use reliable methods of birth control while on treatment with Ado Trastuzumab Emtansine.
Breast Feeding
unsafeAvoid nursing your child while on treatment with Ado Trastuzumab Emtansine as it can cause serious side effects to the newborn baby.
Driving
not applicable-
Liver
cautionIt is unknown how hepatic impairment affects the pharmacokinetics of ado-trastuzumab emtansine conjugate. Hence, inform your doctor if you have any pre-existing liver disease. Your doctor may adjust the dose of the medicine based on the condition. Ado Trastuzumab Emtansine is known to cause hepatotoxicity in some patients. If you notice any reactions such as itching, yellowing of the skin or eyes, dark urine, abdominal pain, unusual bleeding, or pale or dark stools, discontinue the treatment and inform your doctor immediately.
Kidney
cautionLimited data are available on the effect of Ado Trastuzumab Emtansine in kidney-impaired patients. Hence, if you have a pre-existing or a history of kidney disease, inform your doctor.
Children
unsafeAdo Trastuzumab Emtansine is not recommended for use in children as the safety and efficacy are not established.
Habit Forming
Diet & Lifestyle Advise
- Eat small, frequent meals throughout the day to help manage nausea and maintain your energy levels during treatment.
- Drink plenty of fluids, such as water or clear broths, to stay hydrated and help your kidneys process the medication.
- Engage in gentle, low-impact physical activity, like short walks, to help combat fatigue, but always rest when your body tells you to.
- Avoid drinking alcohol, as it can place extra stress on your liver, which is already processing the medication.
- Use a soft toothbrush and be gentle when brushing your teeth to prevent bleeding, especially since this medicine can lower your platelet count.
Special Advise
- Avoid intercourse while on treatment with Ado Trastuzumab Emtansine.
- Regular, complete blood count monitoring is advised during the treatment.
- All patients should be tested for HER2 test before starting the treatment regimen.
- Liver function tests (LFT) and pulmonary function tests (PFT) should be performed before starting the treatment and every 4 to 6 weeks during the treatment.
- Regular ECG and electrolytes should be monitored while receiving the medicine.
Patients Concern
Disease/Condition Glossary
Breast Cancer: Breast cancer is a type of cancer with abnormal growth in the cells of the breast. There are different kinds of breast cancer, such as cancer occurring in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), and in the fatty tissue or the fibrous connective tissue within the breast. Symptoms of breast cancer include a lump in the breast, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, a lump or swelling under the arm, unexplained change in shape, size or appearance of the breast, peeling, flaking or scaling of the skin.
FAQs
Ado Trastuzumab Emtansine is used to treat Breast Cancer.
Ado Trastuzumab Emtansine contains Ado-Trastuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth.
Inform your doctor whether you have received any other breast cancer treatment. Ado Trastuzumab Emtansine may decrease left ventricular ejection fraction, hypersensitivity reactions, hepatotoxicity, liver failure, neurotoxicity, pulmonary toxicity, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, lung problems, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Ado Trastuzumab Emtansine.
It is given as a liquid infusion directly into a vein (IV) by a healthcare professional in a clinic or hospital. Talk to your doctor if you have questions about the infusion process.
While some patients may experience thinning of the hair, complete hair loss is less common with Ado Trastuzumab Emtansine compared to traditional chemotherapy. Talk to your doctor to understand what to expect.
No, you should not become pregnant. This medicine can cause severe birth defects or death to an unborn baby. You must use effective birth control during treatment and for several months afterwards. Talk to your doctor for advice on safe birth control options.
It is typically given once every three weeks, but your doctor will determine the exact schedule based on your specific treatment plan. Talk to your doctor if you need to adjust your schedule.
It is best to avoid alcohol during treatment because both alcohol and Ado Trastuzumab Emtansine are processed by your liver, and combining them can increase the risk of liver damage. Talk to your doctor for personalised advice.
Swelling in your ankles or feet can be a sign of a heart issue. Contact your healthcare team immediately if you experience this symptom. Talk to your doctor right away.
Yes, it contains a powerful cancer-killing chemotherapy drug, but it is linked to a targeted antibody. This helps deliver the chemotherapy directly to the cancer cells, sparing more healthy cells. Talk to your doctor for more details.
Your doctor will order regular blood tests to check your liver function and platelet levels, as well as heart scans (like echocardiograms) to monitor your heart health. Talk to your doctor about your monitoring schedule.
